139 related articles for article (PubMed ID: 34397833)
21. Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Spigel DR; Jotte RM; Aix SP; Gressot L; Morgensztern D; McCleod M; Socinski MA; Daniel D; Juan-Vidal O; Mileham KF; West H; Page R; Reinmuth N; Knoble J; Chen T; Bhore R; Wolfsteiner M; Ong TJ; Gridelli C; Thomas M;
Clin Lung Cancer; 2021 Jan; 22(1):6-15.e4. PubMed ID: 33097414
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung Disease.
Azuma Y; Tamiya M; Shiroyama T; Osa A; Takeoka S; Morishita N; Suzuki H; Okamoto N; Hirashima T; Kawase I
Intern Med; 2015; 54(22):2911-3. PubMed ID: 26568008
[TBL] [Abstract][Full Text] [Related]
23. [Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient].
Ishiura Y; Shiba Y; Terasaki Y; Hinoue Y; Ishida Y; Segawa M; Saitoh K; Hirokami N; Kasahara K; Fujimura M
Gan To Kagaku Ryoho; 2015 Apr; 42(4):493-5. PubMed ID: 25963700
[TBL] [Abstract][Full Text] [Related]
24. [Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)].
Yoshino Y; Miyagi J; Toume R; Naha Y; Uchihara T; Akamine M; Nakazato H; Kawakami M; Tomori T; Nagayoshi S; Nagamine S; Tomiyama T; Ohmine Y; Sasaki H; Ishikawa M; Maeshiro K
Gan To Kagaku Ryoho; 2019 Jul; 46(7):1171-1173. PubMed ID: 31296824
[TBL] [Abstract][Full Text] [Related]
25. A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002).
Wang Z; Huang C; Yang JJ; Song Y; Cheng Y; Chen GY; Yan HH; Ben XS; Wang BC; Xu CR; Jiang BY; Zhou Q; Chen HJ; Wu YL
Eur J Cancer; 2019 Mar; 109():183-191. PubMed ID: 30739019
[TBL] [Abstract][Full Text] [Related]
26. [Pulmonary mucosa-associated lymphoid tissue lymphoma concurrent with lung squamous cell carcinoma: a case report and literature review].
Zhang CS; Yang XR; Ding W; Lu XY; Shen L; Zhao YF
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Dec; 43(12):1071-1076. PubMed ID: 33333642
[No Abstract] [Full Text] [Related]
27. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
[TBL] [Abstract][Full Text] [Related]
28. Clinical Application of Recombinant Human Endostatin in Postoperative Early Complementary Therapy on Patients with Non-small Cell Lung Cancer in Chinese Mainland.
Zhu Q; Zang Q; Jiang ZM; Wang W; Cao M; Su GZ; Zhen TC; Zhang XT; Sun NB; Zhao C
Asian Pac J Cancer Prev; 2015; 16(9):4013-8. PubMed ID: 25987078
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Shu CA; Gainor JF; Awad MM; Chiuzan C; Grigg CM; Pabani A; Garofano RF; Stoopler MB; Cheng SK; White A; Lanuti M; D'Ovidio F; Bacchetta M; Sonett JR; Saqi A; Rizvi NA
Lancet Oncol; 2020 Jun; 21(6):786-795. PubMed ID: 32386568
[TBL] [Abstract][Full Text] [Related]
30. nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial.
Gridelli C; Chen T; Ko A; O'Brien ME; Ong TJ; Socinski MA; Postmus PE
Drug Des Devel Ther; 2018; 12():1445-1451. PubMed ID: 29872267
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus
Araya T; Kita T; Matsuoka H; Sakai T; Kimura H; Kasahara K
Case Rep Oncol; 2020; 13(3):1506-1512. PubMed ID: 33564291
[TBL] [Abstract][Full Text] [Related]
32. Acute cardiac tamponade after Endostar treatment of non-small cell lung cancer: A case report.
Dong W; Wang M; Zhu P; Sun Q; Wu D
Medicine (Baltimore); 2024 May; 103(19):e38106. PubMed ID: 38728498
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
Chen X; Liu Y; Yin Y; Jin S; Ping G; Røe OD; Yan K; Shu Y; Guo R
J Chemother; 2012 Aug; 24(4):231-6. PubMed ID: 23040690
[TBL] [Abstract][Full Text] [Related]
34. Left Lung Neoplasms and Bilateral Pleural Effusion Combined Elevated Carcinoembryonic Antigen in Pleural Effusion with Negative Result of Thoracoscopy Pleural Biopsy Misdiagnosed as Lung Carcinoma Ultimately Confirmed Pulmonary Sarcomatoid Carcinoma by CT-guided Percutaneous Lung Biopsy: a Case Report and Literature Review.
Zhang Q; Wang MH; Li WQ; Wang HY; Rana MA; Chen Y; Liu CH; Zhang S; Jin YX; Zhang C; Zhu XY; Fu AS; Ge YL
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414757
[TBL] [Abstract][Full Text] [Related]
35. Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.
Zeng J; Yin J; Yuan D; Yang W; Liang W; Wu G; Song Y
Clin Respir J; 2017 Sep; 11(5):632-639. PubMed ID: 26404101
[TBL] [Abstract][Full Text] [Related]
36. Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy? a retrospective study.
Chu TQ; Ding H; Garfield DH; Gu AQ; Pei J; Du WD; Han BH
J Thorac Oncol; 2012 Dec; 7(12):1781-1789. PubMed ID: 23154549
[TBL] [Abstract][Full Text] [Related]
37. Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Yoneshima Y; Morita S; Ando M; Miura S; Yoshioka H; Abe T; Kato T; Kondo M; Hosomi Y; Hotta K; Yamamoto N; Kishimoto J; Nakanishi Y; Okamoto I
Clin Lung Cancer; 2017 Jan; 18(1):100-103. PubMed ID: 28341108
[TBL] [Abstract][Full Text] [Related]
38. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Akiyama N; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Uto T; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Suda T
Invest New Drugs; 2019 Jun; 37(3):531-537. PubMed ID: 30790149
[TBL] [Abstract][Full Text] [Related]
39. Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.
Matsubara T; Uchi H; Haratake N; Takamori S; Toyozawa R; Miura N; Yamaguchi M; Seto T; Takenoyama M
Clin Lung Cancer; 2020 Mar; 21(2):e54-e56. PubMed ID: 31874730
[No Abstract] [Full Text] [Related]
40. [Complete Remission after Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Non-Small-Cell Lung Cancer].
Sugiura Y; Hashizume T; Kawai O; Ohkubo Y; Fusegawa H; Araki N; Kaseda S; Nemoto E
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1095-7. PubMed ID: 26469167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
